Clinical trial
Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
NCT00466713 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00466713 |
|---|---|
| Title | Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy |
| Official title | Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy |
| Lead sponsor | Stanford University, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Dilated Cardiomyopathy |
| Intervention type | Drug |
| Interventions | Rosiglitazone therapy |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 27, 2007 |
| Last update posted | May 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: